Molecular determinants of P2Y2 nucleotide receptor function: Implications for proliferative and inflammatory pathways in astrocytes

Molecular Neurobiology

Volumn 31, Issue 1-3, 2005, Pages 169-183

  Weisman, Gary A ^a   Wang, M ^a   Kong, Q ^a   Chorna, N E ^b,c   Neary, J T ^d   Sun, Grace Y ^a   González, Fernando A ^b,c   Seye, C I ^a   Erb, L ^a  

^a University of Missouri   (United States)

^b UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^c Research Service   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocytes; Astrogliosis; Growth factor receptors; Inflammation; Integrins; Nucleotides; Proliferation; RGD motif; SH3 binding domain

Indexed keywords

ADENOSINE TRIPHOSPHATE; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; ION CHANNEL; NUCLEOTIDE; RECEPTOR PROTEIN; STEROID RECEPTOR COACTIVATOR 1; STEROID RECEPTOR COACTIVATOR 3; URIDINE TRIPHOSPHATE; PURINE P2 RECEPTOR; PURINE P2Y2 RECEPTOR;

ASTROCYTE; ASTROCYTOSIS; BRAIN SLICE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CEREBELLUM; CONFERENCE PAPER; CYTOSKELETON; DEGENERATIVE DISEASE; EVOLUTIONARY HOMOLOGY; GLIA CELL; HIPPOCAMPUS; HUMAN; IN SITU HYBRIDIZATION; INFLAMMATION; NONHUMAN; ORGANIZATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; RODENT; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ASTROCYTES; CELL PROLIFERATION; HUMANS; INFLAMMATION; MOLECULAR SEQUENCE DATA; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION;

EID: 24644473520     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:31:1-3:169     Document Type: Conference Paper

References (110)

1. Gahtan E. and Overmier J.B. (1999) Inflammatory pafhogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli. Neurosci. Biobehav. Rev. 23(5), 615-633.
2. Rutka J.T., Murakami M., Dirks P.B., et al. (1997) Role of glial filaments in cells and tumors of glial origin: a review. J. Neurosurg. 87(3), 420-430.
3. 7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial cells. Biomed. Res. 14, 47-61.
4. 1 receptor expression in the brain after sensitisation with d-amphetamine. Psychopharmacology (Berl.) 167, 187-194.
5. 2 receptor subtype from NG108-15 neuroblastoma x glioma hybrid cells. Prog. Brain Res. 120, 33-43.
6. Burnstock G. (1972) Purinergic nerves. Pharmacol. Rev. 24(3), 509-581.
7. Burnstock G., Campbell G., Satchell D., and Smythe A. (1970) Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br. J. Pharmacol. 40(4), 668-688.
8. Burnstock G. and Wood J.N. (1996) Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr. Opin. Neurobiol. 6(4), 526-532.
9. Neary J.T., Rathbone M.P., Cattabeni F., Abbracchio M.P., and Burnstock G. (1996) Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19(1), 13-18.
10. Vitolo O.V., Ciotti M.T., Galli C., Borsello T., and Calissano P. (1998) Adenosine and ADP prevent apoptosis in cultured rat cerebellar granule cells. Brain Res. 809(2), 297-301.
11. Ostrom R.S., Gregorian C., Drenan R.M., Gabot K., Rana B.K., and Insel P.A. (2001) Key role for constitutive cyclooxygenase-2 of MDCK cells in basal signaling and response to released ATP. Am. J. Physiol. Cell Physiol. 281(2), C524-C531.
12. Ahmed S.M., Rzigalinski B.A., Willoughby K.A., Sitterding H.A., and Ellis E.F. (2000) Stretch-induced injury alters mitochondrial membrane potential and cellular ATP in cultured astrocytes and neurons. J. Neurochem. 74(5), 1951-1960.
13. Ciccarelli R., Di Iorio P., Giuliani P., et al. (1999) Rat cultured astrocytes release guanine-based purines in basal conditions and after hypoxia/hypoglycemia. Glia 25, 93-98.
14. Bergfeld G.R. and Forrester T. (1992) Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc. Res. 26(1), 40-47.
15. Bodin P. and Burnstock G. (2001) Purinergic signalling: ATP release. Neurochem. Res. 26, 959-969.
16. Pedersen S.F., Nilius B., Lambert I.H., and Hoffmann E.K. (1999) Mechanical stress induces release of ATP from Ehrlich ascites tumor cells. Biochim. Biophys. Acta 1416, 271-284.
17. Sak K. and Webb T.E. (2002) A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch. Biochem. Biophys. 397(1), 131-136.
18. Inbe H. Watanabe S., Miyawaki M., Tanabe E., and Encinas J.A. (2004) Identification and characterization of a cell-surface receptor, P2Y15, for AMP and adenosine. J. Biol. Chem. 279(19), 19,790-19,799.
19. Burnstock G. (2000) P2X receptors in sensory neurones. Br. J. Anaesth. 84(4), 476-488.
20. Ciccarelli R., Ballerini P., Sabatino G., et al. (2001) Involvement of astrocytes in purine-mediated reparative processes in the brain. Int. J. Dev. Neurosci. 19, 395-414.
21. O'Callaghan J.P. and Jensen K.F. (1992) Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neurotoxicology 13(1), 113-122.
22. Menet V., Prieto M., Privat A., and Gimenez y Ribotta M. (2003) Axonal plasticity and functional recovery after spinal cord injury in mice deficient in both glial fibrillary acidic protein and vimentin genes. Proc. Natl. Acad. Sci. USA 100(15), 8999-9004.
23. Eddleston M. and Mucke L. (1993) Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 54(1), 15-36.
24. Norton W.T., Aquino D.A., Hozumi I., Chiu F.C., and Brosnan C.F. (1992) Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17(9), 877-885.
25. Mcgraw J., Hiebert G.W., and Steeves J.D. (2001) Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63(2), 109-115.
26. Neary J.T., Baker L., Jorgensen S.L., and Norenberg M.D. (1994) Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures. Acta Neuropathol. (Berl.) 87(1), 8-13.
27. Brambilla R. and Abbracchio M.P. (2001) Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors. Ann. NY Acad. Sci. 939, 54-62.
28. Brambilla R., Burnstock G., Bonazzi A., Ceruti S., Cattabeni P., and Abbracchio M.P. (1999) Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. Br. J. Pharmacol. 126(3), 563-567.
29. Brambilla R., Neary J.T., Cattabeni P., et al. (2002) Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. J. Neurochem. 83(6), 1285-1296.
30. Franke H., Krugel U., Schmidt R., Grosche J., Reichenbach A., and Illes P. (2001) P2 receptor-types involved in astrogliosis in vivo. Br. J. Pharmacol. 134, 1180-1189.
31. Franke H., Krugel U., and Illes P. (1999) P2 receptor-mediated proliferative effects on astrocytes in vivo. Glia 28(3), 190-200.
32. Neary J.T., Whittemore S.R., Zhu Q., and Norenberg M.D. (1994) Synergistic activation of DNA synthesis in astrocytes by fibroblast growth factors and extracellular ATP. J. Neurochem. 63(2), 490-494.
33. 2Y purinoceptor subtypes recruit different mek activators in astrocytes. Br. J. Pharmacol. 129(5), 927-936.
34. Jacques-Silva M.C., Rodnight R., Lenz G., et al. (2004) P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br. J. Pharmacol. 141(7), 1106-1117.
35. Fumagalli M., Brambilla R., D'Ambrosi N., et al. (2003) Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors. Glia 43, 218-230.
36. Kukley M., Barden J.A., Steinhauser C., and Jabs R. (2001) Distribution of P2X receptors on astrocytes in juvenile rat hippocampus. Glia 36(1), 11-21.
37. 2-green fluorescent protein receptors. Proc. Natl. Acad. Sci. USA 98(9), 5288-5293.
38. King B.F., Neary J.T., Zhu Q., Wang S., Norenberg M.D., and Burnstock G. (1996) P2 purinoceptors in rat cortical astrocytes: expression, calcium-imaging and signalling studies. Neuroscience 74(4), 1187-1196.
39. Scemes E., Duval N., and Meda P. (2003) Reduced expression of P2Y1 receptors in connexin43-null mice alters calcium signaling and migration of neural progenitor cells. J. Neurosci. 23(36), 11,444-11,452.
40. Chen W.C. and Chen C.C. (1998) ATP-induced arachidonic acid release in cultured astrocytes is mediated by Gi protein coupled P2Y1 and P2Y2 receptors. Glia 22(4), 360-370.
41. Kim S.G., Soltysiak K.A., Gao Z.G., Chang T.S., Chung E., and Jacobson K.A. (2003) Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 65(6), 923-931.
42. Moore D.J., Murdock P.R., Watson J.M., et al. (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: possible role in neuroimmune function. Brain Res. Mol. Brain Res. 118(1-2), 10-23.
43. Lustig K.D., Erb L., Landis D.M., et al. (1992) Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells. Biochim. Biophys. Acta 1134(1), 61-72.
44. 2 nucleotide receptors mediate uridine 5′-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 106(21), 2720-2726.
45. Pillois X., Chaulet H., Belloc I., Dupuch F., Desgranges C., and Gadeau A.P. (2002) Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ. Res. 90(6), 678-681.
46. Kunapuli S.P. and Daniel J.L. (1998) P2 receptor subtypes in the cardiovascular system. Biochem. J. 336(3), 513-523.
47. Kim K.C., Park H.R., Shin C.Y., Akiyama T., and Ko K.H. (1996) Nucleotide-induced mucin release from primary hamster tracheal surface epithelial cells involves the P2u purinoceptor. Eur. Respir. J. 9(7), 1579.
48. Berti-Mattera L.N., Wilkins P.L., Madhun Z., and Suchovsky D. (1996) P2-purigenic receptors regulate phospholipase C and adenylate cyclase activities in immortalized Schwann cells. Biochem. J. 314(2), 555-561.
49. Ho C., Hicks J., and Salter M.W. (1995) A novel P2-purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat. Br. J. Pharmacol. 116(7), 2909-2918.
50. 2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J. Physiol. 483(1), 41-57.
51. Miyagi Y., Kobayashi S., Ahmed A., Nishimura J., Fukui M., and Kanaide H. (1996) P2U purinergic activation leads to the cell cycle progression from the G1 to the S and M phases but not from the G0 to G1 phase in vascular smooth muscle cells in primary culture. Biochem. Biophys. Res. Commun. 222(2), 652-658.
52. Muscella A., Elia M.G., Greco S., Storelli C., and Marsigliante S. (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J. Cell. Physiol. 195(2), 234-240.
53. 2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. J. Biol. Chem. 278(27), 24,960-24,965.
54. 2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc. Natl. Acad. Sci. USA 94(3), 831-836.
55. 2 nucleotide receptors in rat salivary gland cells during short-term culture. Am. J. Physiol. 273(3), C1100-C1107.
56. Xu J., Chalimoniuk M., Shu Y., et al. (2003) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostaglandins Leukotriene Essent. Fatty Acids 69(6), 437-448.
57. Xu J., Weng Y.I., Simonyi A., et al. (2002) Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83(2), 259-270.
58. 2 receptor-stimulated release of prostaglandin E2 by rat inner medullary collecting duct preparations. Am. J. Physiol. Renal Physiol. 285(4), F711-F721.
59. Mohaupt M.G., Fischer T., Schwobel J., Sterzel R.B., and Schulze-Lohoff E. (1998) Activation of purinergic P2Y2 receptors inhibits inducible NO synthase in cultured rat mesangial cells. Am. J. Physiol. 275(1), F103-F110.
60. Yamakuni H., Kawaguchi N., Ohtani Y., et al. (2002) ATP induces leukemia inhibitory factor mRNA in cultured rat astrocytes. J. Neuroimmunol. 129(1-2), 43-50.
61. 2 receptors and increased mitogenic responses to UTP and ATP. Arterioscler. Thromb. Vasc. Biol. 20(9), 2064-2069.
62. 2 receptors in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 258(3), 648-652.
63. Marrelli S.P., Khorovets A., Johnson T.D., Childres W.F., and Bryan R.M., Jr. (1999) P2 purinoceptor-mediated dilations in the rat middle cerebral artery after ischemia-reperfusion. Am. J. Physiol. 276(1), H33-H41.
64. Kannan S. (2003) Neutrophil chemotaxis: potential role of chemokine receptors in extracellular nucleotide induced Mac-1 expression. Med. Hypotheses 61(5,6), 577-579.
65. Turner J.T., Park M., Camden J.M., and Weisman G.A. (1998) Salivary gland nucleotide receptors. Changes in expression and activity related to development and tissue damage. Ann. NY Acad. Sci. 842, 70-75.
66. Dennis E.A. (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269(18), 13,057-13,060.
67. 2 regulation of arachidonic acid mobilization. FEBS Lett. 531(1), 2-6.
68. Martin K.A., Kertesy S.B., and Dubyak G.R. (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol. Pharmacol. 51(1), 97-108.
69. 7 nucleotide receptor activation enhances IFNγ-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem. 87(2), 344-352.
70. Kopp S. (2001) Neuroendocrine, immune, and local responses related to temporomandibular disorders. J. Orofac. Pain 15(1), 9-28.
71. Vancheri C., Mastruzzo C., Sortino M.A., and Crimi N. (2004) The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 25(1), 40-46.
72. Karaki S.I. and Kuwahara A. (2004) Regulation of intestinal secretion involved in the interaction between neurotransmitters and prostaglandin E2. Neurogastroenterol. Motil. 1, 96-99.
73. Ferreira S.H., Moncada S., and Vane J.R. (1997) Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. 1973. Br. J. Pharmacol. 120(4 Suppl.), 401-412; discussion 399-400.
74. o-mediated signal transduction. J. Cell Biol. 153(3), 491-501.
75. 1 for gene delivery to proliferating VSMCs: synergistic effect of TGF-β1. Am. J. Physiol. Heart Circ. Physiol. 285, H1123-H1131.
76. Hutchings H., Ortega N., and Plouet J. (2003) Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J. 17(11), 1520-1522.
77. 5 integrin expression. Cancer Res. 63(14), 4258-4267.
78. 5-mediated cell migration. J. Cell Biol. 158, 1287-1297.
79. Greig A.V., Linge C., Terenghi G., Mcgrouther D.A., and Burnstock G. (2003) Purinergic receptors are part of a functional signaling system for proliferation and differentiation of human epidermal keratinocytes. J. Invest. Dermatol. 120(6), 1007-1015.
80. Schafer R., Sedehizade F., Weite T., and Reiser G. (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am. J. Physiol. Lung Cell Mol Physiol. 285(2), L376-L385.
81. Wilden P.A., Agazie Y.M., Kaufman R., and Halenda S.P. (1998) ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am. J. Physiol. 275(4), H1209-H1215.
82. Gungabissoon R.A. and Bamburg J.R. (2003) Regulation of growth cone actin dynamics by ADF/cofilin. J. Histochem. Cytochem. 51(4), 411-420.
83. Lin T., Zeng L., Liu Y., et al. (2003) Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins. Circ. Res. 92(12), 1296-1304.
84. Rodgers E.E. and Theibert A.B. (2002) Functions of PI 3-kinase in development of the nervous system. Int. J. Dev. Neurosci. 20(3-5), 187-197.
85. Chan-Ling T. and Stone J. (1991) Factors determining the migration of astrocytes into the developing retina: migration does not depend on intact axons or patent vessels. J. Comp. Neurol. 303(3), 375-386.
86. 3 are upregulated during formation of the glial scar after focal stroke. Stroke 29(8), 1698-1706; discussion 1707.
87. Cao W., Luttrell L.M., Medvedev A.V., et al. (2000) Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J. Biol. Chem. 275(49), 38,131-38,134.
88. Green S.A. and Liggett S.B. (1994) A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration. J. Biol. Chem. 269(42), 26,215-26,219.
89. Tang Y., Hu L.A., Miller W.E., et al. (1999) Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 96(22), 12,559-12,564.
90. Oldenhof J., Vickery R., Anafi M., et al. (1998) SH3 binding domains in the dopamine D4 receptor. Biochemistry 37(45), 15,726-15,736.
91. Luttrell L.M., Della Rocca G.J., Van Biesen T., Luttrell D.K., and Lefkowitz R.J. (1997) Gβγ subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272(7), 4637-4644.
92. Andreev J., Galisteo M.L., Kranenburg O., et al. (2001) Src and Pyk2 mediate G-protein-coupled receptor activation of epidermal growth factor receptor (EGFR) but are not required for coupling to the mitogen-activated protein (MAP) kinase signaling cascade. J. Biol. Chem. 276(23), 20,130-20,135.
93. i elevation can substitute for receptor activation. J. Biol. Chem. 273, 23,110-23,117.
94. 2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase C. J. Biol. Chem. 273(5), 2653-2660.
95. 2 nucleotide receptor interact with Src and regulate activities of Src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 279(9), 8212-8218.
96. Avraham H., Park S.Y., Schinkmann K., and Avraham S. (2000) RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 12(3), 123-133.
97. Du Q.S., Ren X.R., Xie Y., Wang Q., Mei L., and Xiong W.C. (2001) Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. J. Cell Sci. 114(16), 2977-2987.
98. Lim I.J., Phan T.T., Tan E.K., et al. (2003) Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and extracellular matrix production in keloids. J. Biol. Chem. 278(42), 40,851-40,858.
99. Menu E., Kooijman R., Van Valckenborgh E., et al. (2004) Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model. Br. J. Cancer 90(5), 1076-1083.
100. Ding X.Z., Tong W.G., and Adrian T.E. (2003) Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer. Oncology 65(4), 285-294.
101. Schafer M., Schafer C., Ewald N., Piper H.M., and Noll T. (2003) Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circ. Res. 92(9), 1010-1015.
102. Johnson G.L. and Lapadat R. (2002) Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912.
103. Daub H., Wallasch C., Lankenau A., Herrlich A., and Ullrich A. (1997) Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16(23), 7032-7044.
104. Qiao M., Shapiro P., Kumar R., and Passaniti A. (2004) Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a PI3K/ERK-dependent and Akt-independent signaling pathway. J. Biol. Chem. [E-pub ahead of press].
105. Okkenhaug K. and Vanhaesebroeck B. (2003) PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3(4), 317-330.
106. Neary J.T., Kang Y., Bu Y., Yu E., Akong K., and Peters C.M. (1999) Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J. Neurosci. 19(11), 4211-4220.
107. Neary J.T., Zhu Q., Kang Y., and Dash P.K. (1996) Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors. Neuroreport 7(18), 2893-2896.
108. Neary J.T., McCarthy M., Cornell-Bell A., and Kang Y. (1999) Trophic signaling pathways activated by purinergic receptors in rat and human astroglia. Prog. Brain Res. 120, 323-332.
109. 2 nucleotide receptor signaling in human monocytic cells: activation, desensitization and coupling to mitogen-activated protein kinases. J. Cell Physiol. 187(2), 196-208.
110. 7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 284(2), C571-C581.